Endo, Inc. (NDOI)

Market Cap	1.80B
Revenue (ttm)	1.73B -9.5%
Net Income	5.67B
EPS	65.93
Shares Out	76.31M
PE Ratio	0.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	537
Average Volume	99,583
Open	23.54
Previous Close	23.10
Day's Range	23.50 - 23.59
52-Week Range	19.85 - 31.40
Beta	n/a
RSI	65.94
Earnings Date	Aug 6, 2025

About Endo, Inc.

Endo, Inc. operates as a specialty pharmaceutical company that develops, manufactures, markets, and sells various pharmaceutical products and provides life-enhancing therapies in the United States and internationally. It offers specialty medicines, sterile injectables, and generic products. The company offers products for the treatment of conditions in urology, orthopedics, and endocrinology. It also develops additional indications for XIAFLEX in clinical development, including plantar fibromatosis and plantar fasciitis, as well as others in pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 3,116
• Stock Exchange: OTCMKTS
• Ticker Symbol: NDOI